These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 35573755)
1. An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jk El Alaoui K; Benghiat FS; Colard M J Hematol; 2022 Apr; 11(2):66-70. PubMed ID: 35573755 [TBL] [Abstract][Full Text] [Related]
2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582 [TBL] [Abstract][Full Text] [Related]
3. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab. Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194 [TBL] [Abstract][Full Text] [Related]
4. Anti-N and anti-Do Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787 [TBL] [Abstract][Full Text] [Related]
5. Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-M Alloantibody in Myelofibrosis: A Case Report. Alsoreeky MS; Lutfi LK; Altamimi AA; Haddad TH; Khalayleh MS; Alkader MS Cureus; 2023 Dec; 15(12):e50717. PubMed ID: 38234941 [TBL] [Abstract][Full Text] [Related]
6. Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review. Vasanthamohan L; Choo S; Marshall T; Symons YT; Matsui D; Eastabrook G; Solh Z Transfusion; 2020 Oct; 60(10):2448-2455. PubMed ID: 32851670 [TBL] [Abstract][Full Text] [Related]
7. An Unusual Case of Hyperhemolysis Syndrome and Delayed Hemolytic Transfusion Reaction due to Anti-Jk(a) and Anti-P1 Antibodies. Montgomery H; Luo MX; Baker S; Lim MY Case Rep Med; 2023; 2023():5290115. PubMed ID: 38188902 [TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Balbuena-Merle R; Hendrickson JE Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806 [TBL] [Abstract][Full Text] [Related]
9. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease. Gerritsma J; Bongaerts V; Eckhardt C; Heijboer H; Nur E; Biemond B; van der Schoot E; Fijnvandraat K; Br J Haematol; 2022 Feb; 196(3):769-776. PubMed ID: 34632580 [TBL] [Abstract][Full Text] [Related]
10. Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition. Vlachaki E; Gavriilaki E; Kafantari K; Adamidou D; Tsitsikas D; Chasapopoulou E; Anagnostopoulos A; Tsapas A Hemoglobin; 2018; 42(5-6):339-341. PubMed ID: 30626228 [TBL] [Abstract][Full Text] [Related]
16. Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia. Bezirgiannidou Z; Christoforidou A; Kontekaki E; Anastasiadis AG; Papamichos SI; Menexidou H; Margaritis D; Martinis G; Mantadakis E Mediterr J Hematol Infect Dis; 2016; 8(1):e2016053. PubMed ID: 27872733 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Aygun B; Padmanabhan S; Paley C; Chandrasekaran V Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310 [TBL] [Abstract][Full Text] [Related]
18. Utility of hemoglobin electrophoresis to distinguish between severe delayed hemolytic transfusion reaction versus hyperhemolysis syndrome. Lukin R; Law JY; Lokhandwala PM Transfus Apher Sci; 2024 Jun; 63(3):103919. PubMed ID: 38582651 [TBL] [Abstract][Full Text] [Related]
19. Acute Hyperhemolysis Syndrome in a Patient with Known Sickle Cell Anemia Refractory to Steroids and IVIG Treated with Tocilizumab and Erythropoietin: A Case Report and Review of Literature. Menakuru SR; Priscu A; Dhillon V; Salih A Hematol Rep; 2022 Jul; 14(3):235-239. PubMed ID: 35893156 [TBL] [Abstract][Full Text] [Related]
20. Alloimmunization and hyperhemolysis in sickle cell disease. Pirenne F; Pondarré C Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):653-659. PubMed ID: 38066873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]